{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T11:37:04Z","timestamp":1791286624692,"version":"4.1.0"},"reference-count":51,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2008,11,1]],"date-time":"2008-11-01T00:00:00Z","timestamp":1225497600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,5,5]],"date-time":"2014-05-05T00:00:00Z","timestamp":1399248000000},"content-version":"vor","delay-in-days":2011,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neoplasia"],"published-print":{"date-parts":[[2008,11]]},"DOI":"10.1593\/neo.08652","type":"journal-article","created":{"date-parts":[[2015,4,23]],"date-time":"2015-04-23T13:05:43Z","timestamp":1429794343000},"page":"1213-IN9","source":"Crossref","is-referenced-by-count":34,"title":["Tissue-Specific Ablation of Prkar1a Causes Schwannomas by Suppressing Neurofibromatosis Protein Production"],"prefix":"10.1016","volume":"10","author":[{"given":"Georgette N.","family":"Jones","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chhavy","family":"Tep","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"II","given":"William H.","family":"Towns","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgeta","family":"Mihai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian D.","family":"Tonks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graham F.","family":"Kay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petra M.","family":"Schmalbrock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anat O.","family":"Stemmer-Rachamimov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung Ok","family":"Yoon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lawrence S.","family":"Kirschner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1593\/neo.08652_bib1","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1086\/513207","article-title":"Germline mutation of INI1\/SMARCB1 in familial schwannomatosis","volume":"80","author":"Hulsebos","year":"2007","journal-title":"Am J Hum Genet"},{"key":"10.1593\/neo.08652_bib2","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1097\/00005792-198507000-00007","article-title":"The complex of myxomas, spotty pigmentation, and endocrine overactivity","volume":"64","author":"Carney","year":"1985","journal-title":"Medicine (Baltimore)"},{"key":"10.1593\/neo.08652_bib3","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0025-6196(12)61843-6","article-title":"Dominant inheritance of the complex of myxomas, spotty pigmentation, and endocrine overactivity","volume":"61","author":"Carney","year":"1986","journal-title":"Mayo Clin Proc"},{"key":"10.1593\/neo.08652_bib4","doi-asserted-by":"crossref","first-page":"4041","DOI":"10.1210\/jcem.86.9.7903","article-title":"Clinical and molecular features of the Carney complex: diagnostic criteria and recommendations for patient evaluation","volume":"86","author":"Stratakis","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1593\/neo.08652_bib5","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/79238","article-title":"Mutations of the gene encoding the protein kinase A type I-alpha regulatory subunit in patients with the Carney complex","volume":"26","author":"Kirschner","year":"2000","journal-title":"Nat Genet"},{"key":"10.1593\/neo.08652_bib6","doi-asserted-by":"crossref","first-page":"4506","DOI":"10.1158\/0008-5472.CAN-05-0580","article-title":"A mouse model for the Carney complex tumor syndrome develops neoplasia in cyclic AMP-responsive tissues","volume":"65","author":"Kirschner","year":"2005","journal-title":"Cancer Res"},{"key":"10.1593\/neo.08652_bib7","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/sj.neo.7900249","article-title":"Mouse models of neurofibromatosis 1 and 2","volume":"4","author":"Gutmann","year":"2002","journal-title":"Neoplasia"},{"key":"10.1593\/neo.08652_bib8","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1126\/science.1068452","article-title":"Neurofibromas in NF1: Schwann cell origin and role of tumor environment","volume":"296","author":"Zhu","year":"2002","journal-title":"Science"},{"key":"10.1593\/neo.08652_bib9","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1002\/glia.20501","article-title":"Mice with GFAP-targeted loss of neurofibromin demonstrate increased axonal MET expression with aging","volume":"55","author":"Su","year":"2007","journal-title":"Glia"},{"key":"10.1593\/neo.08652_bib10","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1002\/jnr.20646","article-title":"Tumorigenic properties of neurofibromin-deficient Schwann cells in culture and as syngrafts in Nf1 knockout mice","volume":"82","author":"Wu","year":"2005","journal-title":"J Neurosci Res"},{"key":"10.1593\/neo.08652_bib11","doi-asserted-by":"crossref","first-page":"5577","DOI":"10.1242\/dev.02162","article-title":"Inactivation of NF1 in CNS causes increased glial progenitor proliferation and optic glioma formation","volume":"132","author":"Zhu","year":"2005","journal-title":"Development"},{"key":"10.1593\/neo.08652_bib12","doi-asserted-by":"crossref","first-page":"8573","DOI":"10.1073\/pnas.0503224102","article-title":"The NF1 tumor suppressor critically regulates TSC2 and mTOR","volume":"102","author":"Johannessen","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1593\/neo.08652_bib13","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.cub.2007.11.066","article-title":"TORC1 is essential for NF1-associated malignancies","volume":"18","author":"Johannessen","year":"2008","journal-title":"Curr Biol"},{"key":"10.1593\/neo.08652_bib14","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1111\/j.1460-9568.2006.05238.x","article-title":"Restored plasticity in a mouse model of neurofibromatosis type 1 via inhibition of hyperactive ERK and CREB","volume":"25","author":"Guilding","year":"2007","journal-title":"Eur J Neurosci"},{"key":"10.1593\/neo.08652_bib15","doi-asserted-by":"crossref","first-page":"5584","DOI":"10.1523\/JNEUROSCI.4693-04.2005","article-title":"Neurofibromin regulates neural stem cell proliferation, survival, and astroglial differentiation in vitro and in vivo","volume":"25","author":"Dasgupta","year":"2005","journal-title":"J Neurosci"},{"key":"10.1593\/neo.08652_bib16","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1101\/gad.1054703","article-title":"Dynamic regulation of the Ras pathway via proteolysis of the NF1 tumor suppressor","volume":"17","author":"Cichowski","year":"2003","journal-title":"Genes Dev"},{"key":"10.1593\/neo.08652_bib17","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1158\/0008-5472.CAN-06-1608","article-title":"Merlin\/neurofibromatosis type 2 suppresses growth by inhibiting the activation of Ras and Rac","volume":"67","author":"Morrison","year":"2007","journal-title":"Cancer Res"},{"key":"10.1593\/neo.08652_bib18","first-page":"1493","article-title":"Overexpression of the NF2 gene inhibits schwannoma cell proliferation through promoting PDGFR degradation","volume":"23","author":"Fraenzer","year":"2003","journal-title":"Int J Oncol"},{"key":"10.1593\/neo.08652_bib19","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1038\/sj.onc.1202141","article-title":"Ruffling membrane, stress fiber, cell spreading and proliferation abnormalities in human Schwannoma cells","volume":"17","author":"Pelton","year":"1998","journal-title":"Oncogene"},{"key":"10.1593\/neo.08652_bib20","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.spen.2006.01.007","article-title":"The genetic and molecular pathogenesis of NF1 and NF2","volume":"13","author":"Yohay","year":"2006","journal-title":"Semin Pediatr Neurol"},{"key":"10.1593\/neo.08652_bib21","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1002\/gene.10242","article-title":"Tyrosinase-Cre mice for tissue-specific gene ablation in neural crest and neuroepithelial-derived tissues","volume":"37","author":"Tonks","year":"2003","journal-title":"Genesis"},{"key":"10.1593\/neo.08652_bib22","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1002\/dvg.20362","article-title":"Development of a pituitary-specific cre line targeted to the Pit-1 lineage","volume":"46","author":"Yin","year":"2008","journal-title":"Genesis"},{"key":"10.1593\/neo.08652_bib23","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/S0076-6879(05)07003-5","article-title":"Schwann cell preparation from single mouse embryos: analyses of neurofibromin function in Schwann cells","volume":"407","author":"Ratner","year":"2005","journal-title":"Methods Enzymol"},{"key":"10.1593\/neo.08652_bib24","doi-asserted-by":"crossref","first-page":"10307","DOI":"10.1158\/0008-5472.CAN-05-3183","article-title":"Disruption of protein kinase a regulation causes immortalization and dysregulation of D-type cyclins","volume":"65","author":"Nadella","year":"2005","journal-title":"Cancer Res"},{"key":"10.1593\/neo.08652_bib25","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1038\/5007","article-title":"Generalized lacZ expression with the ROSA26 Cre reporter strain","volume":"21","author":"Soriano","year":"1999","journal-title":"Nat Genet"},{"key":"10.1593\/neo.08652_bib26","doi-asserted-by":"crossref","first-page":"3718","DOI":"10.1158\/0008-5472.CAN-03-4079","article-title":"Comparative pathology of nerve sheath tumors in mouse models and humans","volume":"64","author":"Stemmer-Rachamimov","year":"2004","journal-title":"Cancer Res"},{"key":"10.1593\/neo.08652_bib27","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/0092-8674(90)90150-D","article-title":"The GAP-related domain of the neurofibromatosis type 1 gene product interacts with ras p21","volume":"63","author":"Martin","year":"1990","journal-title":"Cell"},{"key":"10.1593\/neo.08652_bib28","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/0092-8674(90)90149-9","article-title":"The catalytic domain of the neurofibromatosis type 1 gene product stimulates ras GTPase and complements ira mutants of S. cerevisiae","volume":"63","author":"Xu","year":"1990","journal-title":"Cell"},{"key":"10.1593\/neo.08652_bib29","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1074\/jbc.C100553200","article-title":"p21-Activated kinase links Rac\/Cdc42 signaling to merlin","volume":"277","author":"Xiao","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1593\/neo.08652_bib30","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S1534-5807(01)00009-0","article-title":"The Nf2 tumor suppressor, merlin, functions in Rac-dependent signaling","volume":"1","author":"Shaw","year":"2001","journal-title":"Dev Cell"},{"key":"10.1593\/neo.08652_bib31","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/S1097-2765(03)00382-4","article-title":"Merlin, the product of the Nf2 tumor suppressor gene, is an inhibitor of the p21-activated kinase, Pak1","volume":"12","author":"Kissil","year":"2003","journal-title":"Mol Cell"},{"key":"10.1593\/neo.08652_bib32","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/S0014-5793(01)02309-2","article-title":"Phosphorylation of neurofibromin by cAMP-dependent protein kinase is regulated via a cellular association of N(G),N(G)-dimethylarginine dimethylaminohydrolase","volume":"494","author":"Tokuo","year":"2001","journal-title":"FEBS Lett"},{"key":"10.1593\/neo.08652_bib33","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/0014-5793(96)00137-8","article-title":"Phosphorylation of neurofibromatosis type 1 gene product (neurofibromin) by cAMP-dependent protein kinase","volume":"382","author":"Izawa","year":"1996","journal-title":"FEBS Lett"},{"key":"10.1593\/neo.08652_bib34","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1523\/JNEUROSCI.21-04-01110.2001","article-title":"Schwann cell proliferative responses to cAMP and Nf1 are mediated by cyclin D1","volume":"21","author":"Kim","year":"2001","journal-title":"J Neurosci"},{"key":"10.1593\/neo.08652_bib35","doi-asserted-by":"crossref","first-page":"18559","DOI":"10.1074\/jbc.M313916200","article-title":"Cyclic AMP-dependent protein kinase phosphorylates merlin at serine 518 independently of p21-activated kinase and promotes merlin-ezrin heterodimerization","volume":"279","author":"Alfthan","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1593\/neo.08652_bib36","doi-asserted-by":"crossref","first-page":"41167","DOI":"10.1074\/jbc.M306149200","article-title":"Merlin links to the cAMP neuronal signaling pathway by anchoring the RIbeta subunit of protein kinase A","volume":"278","author":"Gronholm","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1593\/neo.08652_bib37","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1111\/j.1471-4159.2005.03235.x","article-title":"Activation of NMDA receptors induces protein kinase A-mediated phosphorylation and degradation of matrin 3. Blocking these effects prevents NMDA-induced neuronal death","volume":"94","author":"Giordano","year":"2005","journal-title":"J Neurochem"},{"key":"10.1593\/neo.08652_bib38","doi-asserted-by":"crossref","first-page":"49120","DOI":"10.1074\/jbc.M409746200","article-title":"cAMP-dependent protein kinase regulates ubiquitin-proteasome-mediated degradation and subcellular localization of the nuclear receptor coactivator GRIP1","volume":"279","author":"Hoang","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1593\/neo.08652_bib39","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1161\/01.RES.0000170084.88780.ea","article-title":"Phosphorylation of serine 188 protects RhoA from ubiquitin\/proteasome-mediated degradation in vascular smooth muscle cells","volume":"96","author":"Rolli-Derkinderen","year":"2005","journal-title":"Circ Res"},{"key":"10.1593\/neo.08652_bib40","doi-asserted-by":"crossref","first-page":"2962","DOI":"10.1093\/hmg\/ddl239","article-title":"Depletion of type IA regulatory subunit (RIalpha) of protein kinase A (PKA) in mammalian cells and tissues activates mTOR and causes autophagic deficiency","volume":"15","author":"Mavrakis","year":"2006","journal-title":"Hum Mol Genet"},{"key":"10.1593\/neo.08652_bib41","doi-asserted-by":"crossref","first-page":"3390","DOI":"10.1523\/JNEUROSCI.4865-05.2006","article-title":"Temporal control of Rac in Schwann cell-axon interaction is disrupted in NF2-mutant schwannoma cells","volume":"26","author":"Nakai","year":"2006","journal-title":"J Neurosci"},{"key":"10.1593\/neo.08652_bib42","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1084\/jem.194.1.57","article-title":"Hyperactivation of p21(ras) and the hematopoietic-specific Rho GTPase, Rac2, cooperate to alter the proliferation of neurofibromin-deficient mast cells in vivo and in vitro","volume":"194","author":"Ingram","year":"2001","journal-title":"J Exp Med"},{"key":"10.1593\/neo.08652_bib43","doi-asserted-by":"crossref","first-page":"39524","DOI":"10.1074\/jbc.M503707200","article-title":"The neurofibromatosis type 1 gene product neurofibromin enhances cell motility by regulating actin filament dynamics via the Rho-ROCK-LIMK2-cofilin pathway","volume":"280","author":"Ozawa","year":"2005","journal-title":"J Biol Chem"},{"key":"10.1593\/neo.08652_bib44","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1083\/jcb.200610108","article-title":"Essential and distinct roles for cdc42 and rac1 in the regulation of Schwann cell biology during peripheral nervous system development","volume":"177","author":"Benninger","year":"2007","journal-title":"J Cell Biol"},{"key":"10.1593\/neo.08652_bib45","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1083\/jcb.148.2.253","article-title":"RhoA function in lamellae formation and migration is regulated by the alpha6beta4 integrin and cAMP metabolism","volume":"148","author":"O'Connor","year":"2000","journal-title":"J Cell Biol"},{"key":"10.1593\/neo.08652_bib46","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.bbamcr.2004.03.005","article-title":"Regulation of actin-based cell migration by cAMP\/PKA","volume":"1692","author":"Howe","year":"2004","journal-title":"Biochim Biophys Acta"},{"key":"10.1593\/neo.08652_bib47","doi-asserted-by":"crossref","first-page":"19023","DOI":"10.1074\/jbc.M213066200","article-title":"Serine phosphorylation negatively regulates RhoA in vivo","volume":"278","author":"Ellerbroek","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1593\/neo.08652_bib48","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1002\/j.1460-2075.1996.tb00383.x","article-title":"Protein kinase A phosphorylation of RhoA mediates the morphological and functional effects of cyclic AMP in cytotoxic lymphocytes","volume":"15","author":"Lang","year":"1996","journal-title":"EMBO J"},{"key":"10.1593\/neo.08652_bib49","doi-asserted-by":"crossref","first-page":"2811","DOI":"10.1038\/sj.emboj.7600287","article-title":"Anchoring of both PKA and 14-3-3 inhibits the Rho-GEF activity of the AKAP-Lbc signaling complex","volume":"23","author":"Diviani","year":"2004","journal-title":"EMBO J"},{"key":"10.1593\/neo.08652_bib50","doi-asserted-by":"crossref","first-page":"H2427","DOI":"10.1152\/ajpheart.00556.2004","article-title":"cAMP protects endothelial barrier functions by preventing Rac-1 inhibition","volume":"287","author":"Waschke","year":"2004","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1593\/neo.08652_bib51","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1002\/dvg.20362","article-title":"Development of a pituitary-specific cre line targeted to the Pit-1 lineage","volume":"46","author":"Yin","year":"2008","journal-title":"Genesis"}],"container-title":["Neoplasia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1476558608800188?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1476558608800188?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,24]],"date-time":"2019-08-24T00:55:20Z","timestamp":1566608120000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1476558608800188"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,11]]},"references-count":51,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2008,11]]}},"alternative-id":["S1476558608800188"],"URL":"https:\/\/doi.org\/10.1593\/neo.08652","relation":{},"ISSN":["1476-5586"],"issn-type":[{"value":"1476-5586","type":"print"}],"subject":[],"published":{"date-parts":[[2008,11]]}}}